Covance Not Cooling...
Health Care: Drugs
Novelos Therapeutics Inc. (NVLT: OTC)
$0.45 0.00 | 0.00%
05/17/13 - 03:43 PM ET
30.18K / 51.30K
Vol / Avg. Vol:0.44 / 0.45
Open / Prev. Close:0.44 - 0.47
Today's Range:0.36 - 2.01
52 Wk Range:240.91%
Performance YTD:TheStreet Rating:
Portfolios with NVLT
- Portfolio NameUser Type
- Userblackman37
Latest NVLT Headlines from TheStreet
- The Five Dumbest Things on Wall Street: Quiz Answers 09.08.06 | 07:09 am
Press Releases for NVLT
- Novelos Therapeutics Provides Product Pipeline Update - PR Newswire 05.16.13 | 08:05 am
- Novelos Therapeutics Closes $5.5 Million Public Offering - PR Newswire 02.21.13 | 08:02 am
- Novelos Therapeutics Prices $5.5 Million Public Offering - PR Newswire 02.13.13 | 08:02 am
- Novelos Therapeutics To Present At The 15th Annual BIO CEO & Investor Conference On February 11 - PR Newswire 02.04.13 | 08:02 am
- Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: Targeted Radiotherapy International Conference - PR Newswire 01.31.13 | 08:01 am
- Novelos Therapeutics To Present At The Benchmark 2012 Micro Cap Discovery Investor Conference On November 29 - PR Newswire 11.27.12 | 08:11 am
- Novelos Therapeutics Closes $2 Million Private Placement - PR Newswire 11.05.12 | 08:11 am
- Novelos Therapeutics Announces Enrollment Of First Patient In Solid Tumor Imaging Trial With I-124-CLR1404 (LIGHT) Cancer-targeted PET Imaging Agent At UW Carbone Cancer Center - PR Newswire 10.25.12 | 08:10 am
- Novelos Therapeutics And Academic Collaborators Present Diapeutic Technology Platform At Imaging In 2020 Conference - PR Newswire 10.03.12 | 08:10 am
- Novelos Therapeutics To Present At 11th Annual Bio Investor Forum On October 10 - PR Newswire 10.02.12 | 08:10 am
Partner Headlines for NVLT
- NVLT - Development of CLR1502 (GLOW2) Further Expands Pipeline - Analyst Blog - NASDAQ 09.10.12 | 03:09 pm
